D. Davidson

Lovo‐cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB‐206 study

J. Tisdale, Manfred Schmidt, M. Hsieh, 2022, American journal of hematology.

Economic Burden of Comorbidities in Patients with Psoriasis in the USA

Jashin J. Wu, V. Patel, M. Suryavanshi, 2022, Dermatology and Therapy.

Efficacy of aminolevulinic acid 20% solution combined with photodynamic therapy in the treatment of actinic keratoses on the upper extremities: A post hoc analysis of a phase 3, randomized, vehicle-controlled trial.

D. Piacquadio, D. Siegel, B. Berman, 2020, Photodiagnosis and photodynamic therapy.

Clearance of head and neck involvement in plaque psoriasis with tildrakizumab treatment in the phase 3 reSURFACE 1 study

M. Menter, A. Mendelsohn, G. Murakawa, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Treatment patterns and healthcare costs among patients with psoriasis initiating apremilast or biologics: a retrospective claims database cohort analysis.

Jashin J. Wu, Julia Zhu, M. Mittal, 2023, The Journal of dermatological treatment.

Early Discontinuation of Apremilast in Patients with Psoriasis and Gastrointestinal Comorbidities: Rates and Associated Risk Factors

L. Schmidt, S. Kalirai, V. Patel, 2023, Dermatology and Therapy.

Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis

A. Armstrong, V. Chirikov, Wei-Jhih Wang, 2023, Dermatology and Therapy.